“…In 1993, Scheuer and co-workers reported the structure of palauamine (1, Scheme 1), [7] an architecturally interesting alkaloid from the same family. Since then, the pyrroleimidazole alkaloid family (Scheme 2) has been steadily growing, with the isolation of many analogues of sceptrin (3)(4)(5)(6)(7), [8] the ageliferins (8)(9)(10), [9] the nagelamides (11-13), [10] the axinellamines (14)(15)(16)(17), [11] massadine (18), [12] the styloguanidines (19)(20)(21)(22), [13] the konbuacidins (23 and 24), [14] brominated palauamines (26 and 27), [7b] and the stunning tetrameric stylissadines (28 and 29). [15] Recently, the structure of palauamine was called into question and was revised based on a combination of advanced spectroscopic analysis, computation, and even biosynthetic considerations.…”